Study Highlights Participants in the reviewed studies received one of three GLP-1 receptor agonists: Semaglutide 81.5% of patients Liraglutide 17.4% of patients Tirzepatide 1% of patients Following treatment initiation: 58.6% experienced measurable improvement in HS symptoms Dermatology Life Quality Index (DLQI) scores dropped from an average of 13.05 pre-treatment to 9.19 post-treatment, indicating a significant boost in quality of life
The prevention strategies discussed earlier become proportionally more important
While GLP-1 medications offer incredible benefits, they arent suitable for everyone
Testosterone therapy is contraindicated in men attempting to overcome infertility 219,220 A possible exception is nasal testosterone gel, which has been found to have little effect on gonadotropin levels or semen parameters, and may be useful to improve sexual function in men with low testosterone levels
P., and Wu, X
Sept 27, 2024reportedFDA reported to have removed five substances (AOD-9604, CJC-1295, ipamorelin, thymosin alpha-1, selank) from Category 2 after the nominators withdrew their nominations referring them toward advisory-committee review, not approving them